News From Around the System

Studies Find Even Minimal Physical Activity Measurably Boosts Health

Two new studies from UC San Diego find that simply standing up or walking around can provide positive health benefits; and Americans sit too much

HDR@UCR Receives Funds to Address Coronavirus-related Health Disparities

The National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Minority Health and Health Disparities (NIMHD) have awarded a total of $520,000 in funding to the Center for Health Disparities Research at the University of California, Riverside (HDR@UCR) as part of a statewide initiative to address health…

Study Finds Older Adults Using Cannabis to Treat Common Health Conditions

UC San Diego School of Medicine researchers report that older adults are increasingly using cannabis to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.

Study Finds Older Adults Using Cannabis to Treat Common Health Conditions

Data indicates 61 percent of patients who used cannabis began after age 60

J. Silvio Gutkind, PhD, Named Chair of the Department of Pharmacology

J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.

J. Silvio Gutkind, PhD, Named Chair of the Department of Pharmacology

Personalized Cancer Therapy Improves Outcomes in Advanced Disease, Says Study

Patients receiving care at Moores Cancer Center at UC San Diego Health had better outcomes if they received personalized cancer therapy.

Personalized Cancer Therapy Improves Outcomes in Advanced Disease, Says Study

School of Medicine honored by diversity magazine

The UCR School of Medicine has been selected as one of 46 institutions of higher education in the health professions to receive the 2020 Health Professions Higher Education Excellence in Diversity, or HEED, Award from INSIGHT into Diversity magazine.

UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine

UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.